Cognitive deficits of patients with Alzheimer's disease with and without delusions
- PMID: 1734737
- DOI: 10.1176/ajp.149.2.184
Cognitive deficits of patients with Alzheimer's disease with and without delusions
Abstract
Objective: The goal of this investigation was to study the prevalence of delusions in Alzheimer's disease and to compare the performance of the delusional and nondelusional groups on a neuropsychological test battery.
Method: The authors studied 107 patients with Alzheimer's disease and 51 age- and education-comparable normal subjects using a standardized psychiatric interview and a neuropsychological test battery.
Results: Thirty-seven patients with Alzheimer's disease had delusions with or without hallucinations. Patients with delusions were significantly more impaired than those without delusions (and the normal comparison group) on the Mini-Mental State examination; Blessed Information-Memory-Concentration Test; Dementia Rating Scale, especially its conceptualization and memory subtests; and a test of verbal fluency. The delusional group also tended to be somewhat more impaired than the nondelusional group on the modified Wisconsin Card Sorting Test and the similarities subtest of the Wechsler Adult Intelligence Scale-revised.
Conclusions: Approximately one-third of patients with Alzheimer's disease had developed psychotic symptoms sometime after the onset of dementia. The presence of psychotic symptoms in Alzheimer's disease was associated with greater cognitive impairment, especially frontal/temporal dysfunction, and possibly with a more rapidly progressive dementia.
Similar articles
-
Correlation between a reduction in Frontal Assessment Battery scores and delusional thoughts in patients with Alzheimer's disease.Psychiatry Clin Neurosci. 2009 Aug;63(4):449-54. doi: 10.1111/j.1440-1819.2009.01968.x. Epub 2009 Apr 29. Psychiatry Clin Neurosci. 2009. PMID: 19460120 Clinical Trial.
-
More Delusions May Be Observed in Low-Proficient Multilingual Alzheimer's Disease Patients.PLoS One. 2015 Nov 10;10(11):e0140714. doi: 10.1371/journal.pone.0140714. eCollection 2015. PLoS One. 2015. PMID: 26554588 Free PMC article.
-
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. Encephale. 2008. PMID: 19081451 French.
-
Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003.Am J Psychiatry. 2005 Nov;162(11):2022-30. doi: 10.1176/appi.ajp.162.11.2022. Am J Psychiatry. 2005. PMID: 16263838 Review.
-
Neurobiology of delusions in Alzheimer's disease.Curr Psychiatry Rep. 2011 Jun;13(3):211-8. doi: 10.1007/s11920-011-0195-1. Curr Psychiatry Rep. 2011. PMID: 21404128 Review.
Cited by
-
Missing data analysis in drug-naïve Alzheimer's disease with behavioral and psychological symptoms.Yonsei Med J. 2013 Jul;54(4):825-31. doi: 10.3349/ymj.2013.54.4.825. Yonsei Med J. 2013. PMID: 23709414 Free PMC article.
-
Organic psychosis: Insight into the biology of psychosis.Curr Psychiatry Rep. 2001 Aug;3(4):319-25. doi: 10.1007/s11920-001-0028-8. Curr Psychiatry Rep. 2001. PMID: 11470039 Review.
-
Neuropathological and neuroradiological correlates of paranoid symptoms in organic mental disease.Eur Arch Psychiatry Clin Neurosci. 1997;247(4):190-4. doi: 10.1007/BF02900215. Eur Arch Psychiatry Clin Neurosci. 1997. PMID: 9332901 Review.
-
Clinical Aspects of Neurobehavioral Symptoms of Dementia.Dement Neurocogn Disord. 2020 Jun;19(2):54-64. doi: 10.12779/dnd.2020.19.2.54. Dement Neurocogn Disord. 2020. PMID: 32602280 Free PMC article. Review.
-
Increased retention of tau PET ligand [18F]-AV1451 in Alzheimer's Disease Psychosis.Transl Psychiatry. 2022 Feb 26;12(1):82. doi: 10.1038/s41398-022-01850-z. Transl Psychiatry. 2022. PMID: 35217635 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical